Cargando…
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
No specific treatment for COVID-19 infection is available up till now, and there is a great urge for effective treatment to reduce morbidity and mortality during this pandemic. We aimed to evaluate the effect of combining chloroquine/hydroxychloroquine (CQ/HCQ) and zinc in the treatment of COVID-19...
Autores principales: | Abd-Elsalam, Sherief, Soliman, Shaimaa, Esmail, Eslam Saber, Khalaf, Mai, Mostafa, Ehab F., Medhat, Mohammed A., Ahmed, Ossama Ashraf, El Ghafar, Mohamed Samir Abd, Alboraie, Mohamed, Hassany, Sahar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695238/ https://www.ncbi.nlm.nih.gov/pubmed/33247380 http://dx.doi.org/10.1007/s12011-020-02512-1 |
Ejemplares similares
-
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020) -
Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022) -
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021) -
Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021) -
Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)